Provided by Tiger Trade Technology Pte. Ltd.

Immunic, Inc.

16.50
+0.40002.48%
Volume:147.69K
Turnover:2.43M
Market Cap:224.40M
PE:-4.13
High:16.83
Open:16.22
Low:16.20
Close:16.10
52wk High:17.43
52wk Low:5.06
Shares:13.60M
Float Shares:11.92M
Volume Ratio:0.87
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9979
EPS(LYR):-6.2414
ROE:-138.17%
ROA:-66.80%
PB:1.76
PE(LYR):-2.64

Loading ...

Stifel Nicolaus Reaffirms Their Buy Rating on Immunic (IMUX)

TIPRANKS
·
May 29

Immunic presents new Phase 2 CALLIPER analyses of vidofludimus calcium in progressive multiple sclerosis at CMSC 2026

Reuters
·
May 28

Eqs-News: Immunic to Present Additional Phase 2 Calliper Trial Data for Vidofludimus Calcium at the Cmsc Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis

THOMSON REUTERS
·
May 28

Immunic Appoints New CEO to Lead MS Strategy

TIPRANKS
·
May 27

Immunic names ex-Genentech executive Erik Lundgren CEO, replacing Daniel Vitt

Reuters
·
May 27

Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer

THOMSON REUTERS
·
May 27

Immunic Is Maintained at Buy by B. Riley Securities

Dow Jones
·
May 22

B. Riley cuts Immunic target, sees ‘compelling entry point’

TIPRANKS
·
May 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cardiff Oncology (CRDF), ACADIA Pharmaceuticals (ACAD) and Immunic (IMUX)

TIPRANKS
·
May 22

B. Riley Adjusts Price Target on Immunic to $27 From $40, Maintains Buy Rating

MT Newswires Live
·
May 22

Immunic director Michael W. Bonney files initial beneficial ownership statement

Reuters
·
May 20

Immunic names Michael Bonney board chair, replacing interim chair Simona Skerjanec

Reuters
·
May 19

Immunic Inc - Simona Skerjanec Transitions From Interim Chairperson to Board Member

THOMSON REUTERS
·
May 19

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors

THOMSON REUTERS
·
May 19

Immunic (IMUX) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 18

Immunic price target lowered to $19 from $26 at Roth Capital

TIPRANKS
·
May 14

Immunic (IMUX) Gets a Buy from H.C. Wainwright

TIPRANKS
·
May 14

Immunic Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Immunic Q1 EPS $(1.08) Misses $(0.91) Estimate

Benzinga Earnings
·
May 13

Immunic Q1 Basic EPS USD -1.08

THOMSON REUTERS
·
May 13